chr22-50603235-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The ENST00000329492.6(MAPK8IP2):c.184C>A(p.Leu62Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000329492.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAPK8IP2 | NM_012324.6 | c.184C>A | p.Leu62Met | missense_variant | 3/12 | ENST00000329492.6 | NP_036456.1 | |
MAPK8IP2 | XM_011530679.3 | c.184C>A | p.Leu62Met | missense_variant | 3/12 | XP_011528981.1 | ||
MAPK8IP2 | XM_011530680.3 | c.184C>A | p.Leu62Met | missense_variant | 3/12 | XP_011528982.1 | ||
MAPK8IP2 | XM_011530681.3 | c.184C>A | p.Leu62Met | missense_variant | 3/12 | XP_011528983.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAPK8IP2 | ENST00000329492.6 | c.184C>A | p.Leu62Met | missense_variant | 3/12 | 1 | NM_012324.6 | ENSP00000330572.4 | ||
MAPK8IP2 | ENST00000008876.7 | n.103C>A | non_coding_transcript_exon_variant | 1/10 | 1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1457834Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 725056
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 03, 2024 | The c.184C>A (p.L62M) alteration is located in exon 3 (coding exon 3) of the MAPK8IP2 gene. This alteration results from a C to A substitution at nucleotide position 184, causing the leucine (L) at amino acid position 62 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.